PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.4410
-0.0154 (-3.37%)
At close: Sep 25, 2026, 4:00 PM EDT
0.4280
-0.0130 (-2.95%)
Pre-market: Sep 28, 2026, 4:08 AM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $4.73 million as of September 25, 2026. Its market cap has decreased by -35.14% in one year.
Market Cap
4.73M
Enterprise Value
-25.78M
1-Year Change
-35.14%
Ranking
Category
Stock Price
$0.44
ChartMarket Cap Chart
Since August 10, 2021, PharmaCyte Biotech's market cap has decreased from $4.90M to $4.73M, a decrease of -3.38%. That is a compound annual growth rate of -0.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.70M | -35.62% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 957.14% |
| Aug 10, 2021 | 4.90M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 5.60M |
| NuCana | 5.52M |
| Lexaria Bioscience | 5.42M |
| Can-Fite BioPharma | 4.87M |
| Dermata Therapeutics | 4.59M |
| GRI Bio | 4.48M |
| Calidi Biotherapeutics | 4.18M |
| 60 Degrees Pharmaceuticals | 4.11M |